Comparison of Efficacy and Safety of Different Second-line Therapies for Patients With Advanced Thymic Carcinoma

Autor: Shao, K. ∗, †, 1, Hao, Y. †, ‡, 1, Xu, M. †, ‡, 1, Shi, Z. ∗, †, Lin, G. §, Xu, C. , Zhang, Y. ||, Song, Z.
Zdroj: In Clinical Oncology November 2024 36(11):710-718
Databáze: ScienceDirect